Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle Dymanus

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Annals of Translational Medicine|May 2, 2020
Elevated suicide risk among patients with urologic malignancies: highlighting at-risk populationsRashid K Sayyid, Christopher J D Wallis, Kyle Dymanus, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2017
Immunoengineering nerve repairNassir Mokarram, Kyle Dymanus, Akhil Srinivasan, et al.
The Prostate|August 18, 2022
Are higher pre-diagnosis follicle stimulating hormone levels associated with long-term prostate cancer risk?Kyle Dymanus, Lauren E Howard, Taofik Oyekunle, et al.
Translational Andrology and Urology|November 16, 2023
Are higher follicle-stimulating hormone levels before androgen deprivation therapy for prostate cancer associated with oncological and cardiac outcomes and overall survival?-a population-level analysisKyle Dymanus, Nadine A Friedrich, Lauren E Howard, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Annals of Translational Medicine|May 2, 2020
Elevated suicide risk among patients with urologic malignancies: highlighting at-risk populationsRashid K Sayyid, Christopher J D Wallis, Kyle Dymanus, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2017
Immunoengineering nerve repairNassir Mokarram, Kyle Dymanus, Akhil Srinivasan, et al.
The Prostate|August 18, 2022
Are higher pre-diagnosis follicle stimulating hormone levels associated with long-term prostate cancer risk?Kyle Dymanus, Lauren E Howard, Taofik Oyekunle, et al.
Translational Andrology and Urology|November 16, 2023
Are higher follicle-stimulating hormone levels before androgen deprivation therapy for prostate cancer associated with oncological and cardiac outcomes and overall survival?-a population-level analysisKyle Dymanus, Nadine A Friedrich, Lauren E Howard, et al.
Pageof 1